Protalix BioTherapeutics, Inc. (PLX)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.37
TTM P/E
12.47
Normalized P/E
--
Div Yield
--
Book Value
0.84
P/B Ratio
2.81
Institutional Ownership
21.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.62M | $7.0M | 4.53% | -30.1K | 2026-03-31 |
| MAK CAPITAL ONE LLC | 3.54M | $7.0M | 4.44% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1.22M | $2.0M | 1.53% | -38.5K | 2026-03-31 |
| STATE STREET CORP | 972.8K | $2.0M | 1.22% | +387.6K | 2026-03-31 |
| NORTHERN TRUST CORP | 885.4K | $1.0M | 1.11% | +19.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 865.3K | $1.0M | 1.08% | +35.2K | 2026-03-31 |
| Stratos Wealth Partners, LTD. | 500.0K | $1.0M | 0.63% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 432.5K | -- | 0.54% | -- | 2026-03-31 |
| Prospera Financial Services Inc | 418.6K | -- | 0.52% | -- | 2026-03-31 |
| Opaleye Management Inc. | 340.0K | -- | 0.43% | -2.14M | 2026-03-31 |